{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:30:19Z","timestamp":1792089019462,"version":"4.4.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018609","name":"High-level Hospital Construction Project of Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.canlet.2025.217448","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:39:02Z","timestamp":1736476742000},"page":"217448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["From pathogenesis to precision medicine: Transformative advances in research and treatment of ameloblastoma"],"prefix":"10.1016","volume":"612","author":[{"given":"Zhang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-9380","authenticated-orcid":false,"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217448_bib1","series-title":"WHO. Head and Neck Tumours. Part B","year":"2024"},{"key":"10.1016\/j.canlet.2025.217448_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/odi.13031","article-title":"Global incidence and profile of ameloblastoma: a systematic review and meta\u2010analysis","volume":"26","author":"Hendra","year":"2020","journal-title":"Oral Dis."},{"key":"10.1016\/j.canlet.2025.217448_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijom.2009.11.022","article-title":"Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas","volume":"39","author":"Fregnani","year":"2010","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0022034514556815","article-title":"Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor","volume":"94","author":"Heikinheimo","year":"2015","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.canlet.2025.217448_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijom.2006.11.003","article-title":"Long-term follow up on recurrence of 305 ameloblastoma cases","volume":"36","author":"Hong","year":"2007","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.joms.2012.07.004","article-title":"Mandibular resection and reconstruction in the management of extensive ameloblastoma","volume":"71","author":"Bianchi","year":"2013","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib7","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ijom.2019.04.008","article-title":"Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study","volume":"48","author":"Au","year":"2019","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib8","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s11033-021-06963-0","article-title":"RNA sequencing and its applications in cancer and rare diseases","volume":"49","author":"Ergin","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.canlet.2025.217448_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2012.11.004","article-title":"Genomic sequencing in cancer","volume":"340","author":"Tuna","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.2986","article-title":"Identification of recurrent SMO and BRAF mutations in ameloblastomas","volume":"46","author":"Sweeney","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2025.217448_bib11","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1158\/1078-0432.CCR-14-1069","article-title":"Activating FGFR2\u2013RAS\u2013BRAF mutations in ameloblastoma","volume":"20","author":"Brown","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217448_bib12","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1007\/s13277-015-3238-0","article-title":"Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours","volume":"36","author":"Diniz","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.canlet.2025.217448_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/path.4317","article-title":"High frequency of BRAF V600E mutations in ameloblastoma","volume":"232","author":"Kurppa","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju378","article-title":"Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma","volume":"107","author":"Kaye","year":"2014","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2025.217448_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105854","article-title":"Managing stage 4 ameloblastoma with dual BRAF\/MEK inhibition: a case report with 8-year clinical follow-up","volume":"128","author":"Abramson","year":"2022","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib16","series-title":"WHO Classification of Head and Neck Tumours","year":"2017"},{"key":"10.1016\/j.canlet.2025.217448_bib17","series-title":"Pathology and Genetics of Head and Neck Tumours: ... Reflects the Views of a Working Group that Convened for an Editorial and Consensus Conference in Lyon, France, July 16 - 19, 2003","article-title":"Weltgesundheitsorganisation, international agency for research on cancer","year":"2007"},{"key":"10.1016\/j.canlet.2025.217448_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00428-017-2182-3","article-title":"New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours","volume":"472","author":"Speight","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2025.217448_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12105-021-01404-7","article-title":"Update from the 5th edition of the World Health organization classification of Head and Neck tumors: odontogenic and maxillofacial bone tumours","volume":"16","author":"Vered","year":"2022","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0030-4220(93)90023-W","article-title":"Radiologic features of desmoplastic variant of ameloblastoma","volume":"76","author":"Kaffe","year":"1993","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/00000478-200010000-00008","article-title":"Unicystic ameloblastoma: a clinicopathologic study of 33 Chinese patients","volume":"24","author":"Li","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bjoms.2019.06.002","article-title":"Marsupialisation for the treatment of unicystic ameloblastoma of the mandible: a long-term follow up of 116 cases","volume":"57","author":"Zheng","year":"2019","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib23","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/joms.2001.27522","article-title":"Cystic ameloblastoma\u2014behavior and treatment of 21 cases","volume":"59","author":"Rosenstein","year":"2001","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/odi.13770","article-title":"Conceptual changes in ameloblastoma: suggested re\u2010classification of a \u201cveteran\u201d tumor","volume":"28","author":"Zlotogorski\u2010Hurvitz","year":"2022","journal-title":"Oral Dis."},{"key":"10.1016\/j.canlet.2025.217448_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.adaj.2018.03.029","article-title":"Splitters or lumpers the 2017 WHO classification of Head and Neck tumours","volume":"149","author":"Reichart","year":"2018","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.canlet.2025.217448_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/jop.13334","article-title":"Comparison of survival outcomes between ameloblastic carcinoma and metastasizing ameloblastoma: a systematic review","volume":"51","author":"Chrcanovic","year":"2022","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s12105-021-01358-w","article-title":"Diagnostic enigma of adenoid ameloblastoma: literature review based evidence to consider it as a new sub type of ameloblastoma","volume":"16","author":"Jayasooriya","year":"2022","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.oooo.2015.05.011","article-title":"Adenoid ameloblastoma: clinicopathologic description of five cases and systematic review of the current knowledge","volume":"120","author":"Loyola","year":"2015","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.canlet.2025.217448_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tripleo.2004.02.077","article-title":"Adenoid ameloblastoma with dentinoid: a case report","volume":"98","author":"Evans","year":"2004","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.canlet.2025.217448_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12105-009-0107-4","article-title":"Diagnostically challenging epithelial odontogenic tumors: a selective review of 7 jawbone lesions","volume":"3","author":"Ide","year":"2009","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/jomfp.JOMFP_53_15","article-title":"Adenoid ameloblastoma with dentinoid: a rare hybrid variant","volume":"21","author":"Rai","year":"2017","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.acthis.2018.05.006","article-title":"Ameloblastoma with adenoid features: a series of eight cases","volume":"120","author":"Adorno-Farias","year":"2018","journal-title":"Acta Histochem."},{"key":"10.1016\/j.canlet.2025.217448_bib33","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/jop.13243","article-title":"Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors","volume":"50","author":"Coura","year":"2021","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib34","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/s41379-022-01125-4","article-title":"Adenoid ameloblastoma harbors beta-catenin mutations","volume":"35","author":"Bastos","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/154405910208100805","article-title":"Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray","volume":"81","author":"Heikinheimo","year":"2002","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.canlet.2025.217448_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/gut.52.1.144","article-title":"Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets","volume":"52","author":"Hommes","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2025.217448_bib37","series-title":"Molecular Cell Biology","author":"Lodish","year":"2021"},{"key":"10.1016\/j.canlet.2025.217448_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216264","article-title":"MEK inhibitor and anti-EGFR antibody overcome sotorasib resistance signals and enhance its antitumor effect in colorectal cancer cells","author":"Hondo","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib39","doi-asserted-by":"crossref","unstructured":"Ritt DA. Inhibition of Ras\/Raf\/MEK\/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit n.d. https:\/\/doi.org\/10.1016\/j.molcel.2016.10.029.","DOI":"10.1016\/j.molcel.2016.10.029"},{"key":"10.1016\/j.canlet.2025.217448_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.217448_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216116","article-title":"MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer","volume":"559","author":"Morimoto","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217448_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/med.21288","article-title":"FGF receptors: cancer biology and therapeutics: cancer biology and therapeutics on fgf receptors","volume":"34","author":"Katoh","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.canlet.2025.217448_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216381","article-title":"CD155 and its receptors in cancer immune escape and immunotherapy","volume":"573","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216425","article-title":"Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing","volume":"577","author":"Zhou","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib46","doi-asserted-by":"crossref","DOI":"10.4137\/BIC.S29329","article-title":"Ameloblastoma: a review of recent molecular pathogenetic discoveries","volume":"7s2","author":"Brown","year":"2015","journal-title":"Biomarkers Cancer"},{"key":"10.1016\/j.canlet.2025.217448_bib47","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/ijms21051587","article-title":"Sonic hedgehog signaling and tooth development","volume":"21","author":"Hosoya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217448_bib48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.oraloncology.2005.09.008","article-title":"Epithelial expression of SHH signaling pathway in odontogenic tumors","volume":"42","author":"Zhang","year":"2006","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0092-8674(00)80094-X","article-title":"The Drosophila smoothened gene encodes a seven-pass membrane protein, a putative receptor for the hedgehog signal","volume":"86","author":"Alcedo","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217448_bib50","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1101\/gad.1693608","article-title":"Hedgehog: functions and mechanisms","volume":"22","author":"Varjosalo","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.217448_bib51","article-title":"SHH signaling","author":"Mishra","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.canlet.2025.217448_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of Hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217448_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12964-018-0220-7","article-title":"A highlight on Sonic hedgehog pathway","volume":"16","author":"Carballo","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2025.217448_bib54","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.3390\/cimb46060323","article-title":"Unravelling the mysteries of the sonic hedgehog pathway in cancer stem cells: activity, crosstalk and regulation","volume":"46","author":"Berrino","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.canlet.2025.217448_bib55","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00428-018-2305-5","article-title":"The landscape of genetic alterations in ameloblastomas relates to clinical features","volume":"472","author":"G\u00fcltekin","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.canlet.2025.217448_bib56","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1179386","article-title":"Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma","volume":"326","author":"Yauch","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.217448_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-018-0803-3","article-title":"PTEN\/PTENP1: \u2018Regulating the regulator of RTK-dependent PI3K\/Akt signalling\u2019, new targets for cancer therapy","volume":"17","author":"Haddadi","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217448_bib58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/jclinpath-2016-203650","article-title":"Gene of the month: SMARCB1","volume":"69","author":"Kalimuthu","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216240","article-title":"AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations","volume":"566","author":"Xu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216064","article-title":"The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer","volume":"556","author":"Jiang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216438","article-title":"TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer","volume":"578","author":"Gou","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105946","article-title":"ALK-fusion-positive secondary ameloblastic carcinoma reached complete response after using alectinib","volume":"132","author":"Li","year":"2022","journal-title":"Oral Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0925-4773(97)00115-9","article-title":"Signalling networks regulating dental development","volume":"67","author":"Thesleff","year":"1997","journal-title":"Mech. Dev."},{"key":"10.1016\/j.canlet.2025.217448_bib64","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/0022034510363373","article-title":"Wnt\/\u03b2-catenin signaling in oral tissue development and disease","volume":"89","author":"Liu","year":"2010","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.canlet.2025.217448_bib65","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/00220345211070583","article-title":"MSX1 drives tooth morphogenesis through controlling Wnt signaling activity","volume":"101","author":"Lee","year":"2022","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.canlet.2025.217448_bib66","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0714.2011.01104.x","article-title":"Differential expression of canonical and non\u2010canonical Wnt ligands in ameloblastoma","volume":"41","author":"Siar","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib67","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2353\/ajpath.2010.090478","article-title":"WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors","volume":"176","author":"Sukarawan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2025.217448_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13073","article-title":"Activation of Wnt signalling reduces the population of cancer stem cells in ameloblastoma","volume":"54","author":"Kim","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.canlet.2025.217448_bib69","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1177\/0022034518777746","article-title":"Msx2 prevents stratified squamous epithelium formation in the enamel organ","volume":"97","author":"Nakatomi","year":"2018","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.canlet.2025.217448_bib70","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0714.2006.00393.x","article-title":"Oligonucleotide microarray analysis of ameloblastoma compared with dentigerous cyst","volume":"35","author":"Lim","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib71","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.archoralbio.2015.02.017","article-title":"Expression of the transcription factor PITX2 in ameloblastic carcinoma","volume":"60","author":"Garc\u00eda-Mu\u00f1oz","year":"2015","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.canlet.2025.217448_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1369\/jhc.2008.951707","article-title":"Msx and Dlx homeogene expression in epithelial odontogenic tumors","volume":"57","author":"Ruhin-Poncet","year":"2009","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.canlet.2025.217448_bib73","doi-asserted-by":"crossref","first-page":"27176","DOI":"10.1074\/jbc.M109.033464","article-title":"Critical role of heparin binding domains of ameloblastin for dental epithelium cell adhesion and ameloblastoma proliferation","volume":"284","author":"Sonoda","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217448_bib74","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1002\/jcb.23248","article-title":"Deregulated HOX genes in ameloblastomas are located in physical contiguity to keratin genes","volume":"112","author":"Schiavo","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2025.217448_bib75","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1242\/dev.117887","article-title":"The non-canonical BMP and Wnt\/\u03b2-catenin signaling pathways orchestrate early tooth development","volume":"142","author":"Yuan","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.canlet.2025.217448_bib76","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jcp.21448","article-title":"Physiological implications of DLX homeoproteins in enamel formation","volume":"216","author":"L\u00e9zot","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2025.217448_bib77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1359\/jbmr.2000.15.3.430","article-title":"Biomineralization, life-time of odontogenic cells and differential expression of the two homeobox genes MSX-1 and DLX-2 in transgenic mice","volume":"15","author":"L\u00e9zot","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2025.217448_bib78","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/jbmr.3202","article-title":"Isl1 controls patterning and mineralization of enamel in the continuously renewing mouse incisor","volume":"32","author":"Naveau","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2025.217448_bib79","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1242\/dev.00631","article-title":"Role of Islet1 in the patterning of murine dentition","volume":"130","author":"Mitsiadis","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.canlet.2025.217448_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216023","article-title":"CircPTK2\/PABPC1\/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer","volume":"554","author":"Meng","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216404","article-title":"Cooperation between IRTKS and deubiquitinase OTUD4 enhances the SETDB1-mediated H3K9 trimethylation that promotes tumor metastasis via suppressing E-cadherin expression","volume":"575","author":"Cui","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216262","article-title":"The NF\u2013Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer","volume":"567","author":"Rigillo","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib83","doi-asserted-by":"crossref","first-page":"e801","DOI":"10.1016\/j.jormas.2022.05.026","article-title":"Immunohistochemical expression of E-cadherin, N-cadherin and Snail\/slug in ameloblastoma","volume":"123","author":"Aborisade","year":"2022","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib84","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/odi.13173","article-title":"Interleukin\u20108\/\u03b2\u2010catenin mediates epithelial\u2013mesenchymal transition in ameloblastoma","volume":"25","author":"Zhang","year":"2019","journal-title":"Oral Dis."},{"key":"10.1016\/j.canlet.2025.217448_bib85","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.pathol.2019.04.004","article-title":"Epithelial-to-mesenchymal transition in ameloblastoma: focus on morphologically evident mesenchymal phenotypic transition","volume":"51","author":"Siar","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.canlet.2025.217448_bib86","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00795-016-0149-0","article-title":"Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-\u03b2, and E-cadherin in ameloblastoma","volume":"50","author":"Kurioka","year":"2017","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.canlet.2025.217448_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.900108","article-title":"FOSL1 promotes tumor growth and invasion in ameloblastoma","volume":"12","author":"Xiong","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib88","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1002\/cam4.2667","article-title":"Hypoxia\u2010induced HIF\u20101\u03b1 and ZEB1 are critical for the malignant transformation of ameloblastoma via TGF\u2010\u03b2\u2010dependent EMT","volume":"8","author":"Yoshimoto","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2025.217448_bib89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41368-024-00281-4","article-title":"Single-cell transcriptomics reveals cell atlas and identifies cycling tumor cells responsible for recurrence in ameloblastoma","volume":"16","author":"Xiong","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.canlet.2025.217448_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216143","article-title":"EZH2 and NF-\u03baB: a context-dependent crosstalk and transcriptional regulation in cancer","volume":"560","author":"Kaur","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib91","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embj.201694058","article-title":"A covalently bound inhibitor triggers EZH 2 degradation through CHIP \u2010mediated ubiquitination","volume":"36","author":"Wang","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2025.217448_bib92","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41419-020-2560-7","article-title":"LGR5+ epithelial tumor stem-like cells generate a 3D-organoid model for ameloblastoma","volume":"11","author":"Chang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217448_bib93","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pro.2446","article-title":"Structure and function of LGR5: an enigmatic G\u2010protein coupled receptor marking stem cells","volume":"23","author":"Kumar","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.canlet.2025.217448_bib94","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1101\/gad.235473.113","article-title":"The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength","volume":"28","author":"De Lau","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.217448_bib95","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nature06196","article-title":"Identification of stem cells in small intestine and colon by marker gene Lgr5","volume":"449","author":"Barker","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217448_bib96","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1038\/s41598-022-13056-w","article-title":"LGR5 is a conserved marker of hair follicle stem cells in multiple species and is present early and throughout follicle morphogenesis","volume":"12","author":"Polkoff","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217448_bib97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","article-title":"Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro","volume":"6","author":"Barker","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217448_bib98","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2015.06.024","article-title":"Colorectal cancer-derived tumor spheroids retain the characteristics of original tumors","volume":"367","author":"Lee","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib99","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/1752-1947-5-491","article-title":"Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature","volume":"5","author":"Amzerin","year":"2011","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.canlet.2025.217448_bib100","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1007\/s00405-016-3899-3","article-title":"Treatment of ameloblastoma and ameloblastic carcinoma with radiotherapy","volume":"273","author":"Kennedy","year":"2016","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.canlet.2025.217448_bib101","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib102","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2025.217448_bib103","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib104","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41591-019-0448-9","article-title":"Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma","volume":"25","author":"Ascierto","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib105","article-title":"Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach","author":"Grynberg","year":"2023","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2025.217448_bib106","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw190","article-title":"Durable Treatment of Ameloblastoma with Single Agent BRAFi Re: Clinical and Radiographic Response with Combined BRAF-Targeted Therapy in Stage 4 Ameloblastoma","volume":"109","author":"Faden","year":"2017","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2025.217448_bib107","author":"Fernandes"},{"key":"10.1016\/j.canlet.2025.217448_bib108","author":"Broudic-Guibert"},{"key":"10.1016\/j.canlet.2025.217448_bib109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/27325016211005126","article-title":"Treatment of a BRAF V600E positive ameloblastoma in a pediatric patient with MEK inhibitor monotherapy","volume":"2","author":"Daws","year":"2021","journal-title":"Face"},{"key":"10.1016\/j.canlet.2025.217448_bib110","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3389\/fonc.2019.01204","article-title":"Enabling precision medicine for rare Head and Neck tumors: the example of BRAF\/MEK targeting in patients with metastatic ameloblastoma","volume":"9","author":"Brunet","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib111","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1200\/PO.20.00175","article-title":"Tumor regression after treatment with lenvatinib in FGFR2 -mutated ameloblastoma","author":"Weaver","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib112","first-page":"e1656","article-title":"Precision medicine: sustained response to erdafitinib in FGFR2 \u2010mutant, multiply recurrent ameloblastoma","volume":"5","author":"Lawson\u2010Michod","year":"2022","journal-title":"Cancer Rep."},{"key":"10.1016\/j.canlet.2025.217448_bib113","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.oooo.2015.12.016","article-title":"BRAF inhibitor treatment of primary BRAF -mutant ameloblastoma with pathologic assessment of response","volume":"122","author":"Tan","year":"2016","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.canlet.2025.217448_bib114","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3390\/cancers16122174","article-title":"Anti-MAPK targeted therapy for ameloblastoma: case report with a systematic review","volume":"16","author":"Raemy","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217448_bib115","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/term.3254","article-title":"Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration","volume":"15","author":"Hirschhorn","year":"2021","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib116","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1200\/JCO.20.00762","article-title":"Dabrafenib and trametinib in patients with tumors with BRAF V600E mutations: results of the NCI-MATCH trial subprotocol H","volume":"38","author":"Salama","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib117","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1158\/1078-0432.CCR-21-0066","article-title":"Differential outcomes in codon 12\/13 and codon 61 NRAS -mutated cancers in the phase II NCI-MATCH trial of binimetinib in patients with NRAS -mutated tumors","volume":"27","author":"Cleary","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217448_bib118","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae119","article-title":"Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G","author":"Nelson","year":"2024","journal-title":"Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib119","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nm.3392","article-title":"Tumor adaptation and resistance to RAF inhibitors","volume":"19","author":"Lito","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217448_bib121","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharmthera.2013.10.001","article-title":"MEK in cancer and cancer therapy","volume":"141","author":"Neuzillet","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2025.217448_bib122","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s40265-018-0963-x","article-title":"Encorafenib and binimetinib: first global approvals","volume":"78","author":"Shirley","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.canlet.2025.217448_bib123","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1158\/1078-0432.CCR-20-5032","article-title":"FDA approval summary: selumetinib for plexiform neurofibroma","volume":"27","author":"Casey","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217448_bib124","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1060028016672037","article-title":"Cobimetinib: a novel MEK inhibitor for metastatic melanoma","volume":"51","author":"Signorelli","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.canlet.2025.217448_bib125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nrc.2017.8","article-title":"Advances and challenges in targeting FGFR signalling in cancer","volume":"17","author":"Babina","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217448_bib126","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","article-title":"The FGFR landscape in cancer: analysis of 4,853 tumors by next-generation sequencing","volume":"22","author":"Helsten","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217448_bib127","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13578-023-01156-7","article-title":"Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas","volume":"13","author":"Pu","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.canlet.2025.217448_bib128","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/jpm12101648","article-title":"Towards precision oncology: the role of smoothened and its variants in cancer","volume":"12","author":"Nicheperovich","year":"2022","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.canlet.2025.217448_bib129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13555-020-00378-8","article-title":"Sonidegib: safety and efficacy in treatment of advanced basal cell carcinoma","volume":"10","author":"Villani","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.canlet.2025.217448_bib130","series-title":"Ameloblastomas of the Mandible and Maxilla","author":"Petrovic","year":"2019"},{"key":"10.1016\/j.canlet.2025.217448_bib131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MOO.0000000000000238","article-title":"Ameloblastomas of the mandible and maxilla","volume":"24","author":"Parmar","year":"2016","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib132","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hed.24720","article-title":"Maxillary ameloblastoma: factors associated with risk of recurrence: recurrent factors in maxillary ameloblastoma","volume":"39","author":"Yang","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2025.217448_bib133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.joco.2017.09.001","article-title":"Orbital invasion of ameloblastoma: a systematic review apropos of a rare entity","volume":"30","author":"Abtahi","year":"2018","journal-title":"J. Curr. Ophthalmol."},{"key":"10.1016\/j.canlet.2025.217448_bib134","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jormas.2018.04.017","article-title":"Brain ameloblastoma: metastasis or local extension case report and physipathological reflexion","volume":"119","author":"Bettoni","year":"2018","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s13104-016-2260-7","article-title":"Maxillary unicystic ameloblastoma: a case report","volume":"9","author":"Agani","year":"2016","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.canlet.2025.217448_bib136","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2021.04.003","article-title":"Hedgehog signaling mechanism and role in cancer","volume":"85","author":"Jiang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217448_bib137","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2009.04.035","article-title":"Arsenic trioxide induces apoptosis and G2\/M phase arrest by inducing Cbl to inhibit PI3K\/Akt signaling and thereby regulate p53 activation","volume":"284","author":"Li","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217448_bib138","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1172\/JCI42874","article-title":"Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog\/GLI pathway","volume":"121","author":"Beauchamp","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2025.217448_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114995","article-title":"Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: aberrant activation of the HH-Gli signaling pathway in acquired resistance","volume":"164","author":"Trocchianesi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2025.217448_bib140","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3892\/ijo.2015.3293","article-title":"Targeting hedgehog signalling by arsenic trioxide reduces cell growth and induces apoptosis in rhabdomyosarcoma","volume":"48","author":"Boehme","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117302","article-title":"Analysis of vismodegib resistance in D473G and W535L mutants of SMO receptor and design of novel drug derivatives using molecular dynamics simulations","volume":"244","author":"Liao","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2025.217448_bib142","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/1078-0432.CCR-16-2051","article-title":"FDA approval summary: Sonidegib for locally advanced basal cell carcinoma","volume":"23","author":"Casey","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217448_bib143","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1158\/1078-0432.CCR-19-0365","article-title":"FDA approval summary: Glasdegib for newly diagnosed acute myeloid leukemia","volume":"25","author":"Norsworthy","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217448_bib144","doi-asserted-by":"crossref","first-page":"35","DOI":"10.17116\/patol20218306135","article-title":"Metastatic basal cell carcinoma with a SMO gene mutation. A case report","volume":"83","author":"Zverev","year":"2021","journal-title":"Arkh. Patol."},{"key":"10.1016\/j.canlet.2025.217448_bib145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","article-title":"Tazemetostat: first approval","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.canlet.2025.217448_bib146","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","article-title":"Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study","volume":"21","author":"Gounder","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2025.217448_bib147","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40265-019-01161-6","article-title":"Alpelisib: first global approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.canlet.2025.217448_bib148","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.joms.2006.03.022","article-title":"Ameloblastoma: a surgeon\u2019s dilemma","volume":"64","author":"Ghandhi","year":"2006","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib149","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bjoms.2021.07.022","article-title":"Unicystic ameloblastoma: analysis of surgical management and recurrence risk factors","volume":"60","author":"Titinchi","year":"2022","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib150","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/hed.25867","article-title":"Recurrence factors in pediatric ameloblastoma: clinical features and a new classification system","volume":"41","author":"Yang","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.canlet.2025.217448_bib151","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ijom.2021.11.017","article-title":"Prediction of ameloblastoma recurrence using random forest\u2014a machine learning algorithm","volume":"51","author":"Wang","year":"2022","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.canlet.2025.217448_bib152","article-title":"Machine learning-based radiomics for predicting BRAF-V600E mutations in ameloblastoma","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2025.217448_bib153","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/bioengineering11060571","article-title":"Classification of ameloblastoma, periapical cyst, and chronic suppurative osteomyelitis with semi-supervised learning: the WaveletFusion-ViT model approach","volume":"11","author":"Liang","year":"2024","journal-title":"Bioengineering"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:56:40Z","timestamp":1760741800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":153,"alternative-id":["S0304383525000126"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217448","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From pathogenesis to precision medicine: Transformative advances in research and treatment of ameloblastoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217448"}}